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How to promote vaccinations: a pilot study in the North-West of Italy
Lorenzo Ravetto Enri*, Francesca Baratta*, Irene Pignata, and Paola Brusa
Department of Pharmaceutical Science and Technology, University of Turin, Turin, Italy
ABSTRACT
Background: vaccines are one of the greatest medical discoveries. In various countries, pharmacists are
authorised to administer vaccines directly in pharmacies; thus, leading to an increase in the immunisa-
tion rate and a notable gain in consensus amongst the population.
The main objective was to evaluate the opinion of pharmacy customers regarding the proposal to
authorise pharmacies to administer vaccines.
Results: 85% of the respondents were in favour of the introduction of a vaccinating pharmacist. The
data show more positive attitudes to the introduction of this service amongst subjects with an elderly
dependant relative (PR = 1,10; p = 0.025). Furthermore, it can be noticed a higher probability of positive
attitudes to the establishment of the vaccinating pharmacist amongst those with positive attitudes to
vaccines (PR = 1,15; p = 0.039). Moreover, the pharmacist is seen as a reference on the subject of
vaccines by only 8% of interviewees.
Discussion: The data highlight the particularly positive feedback regarding the subject of pharmacists
being authorised to administer vaccines. This service may, however, encounter obstacles such as
economic problems and opposition from other health professionals.
Materials and methods: Data were gathered through a face-to-face interview by means of question-
naires in eight pharmacies in the north-west of Piedmont (Italy). Descriptive statistics were performed.
The comparison between the proportions and average values was performed by χ2 and t-test. The
indicator used for the associations was the Prevalence Ratio (PR). The PR was calculated using a modified
Poisson regression with robust standard errors. The level of significance was fixed at 0.05; IC at 95%.
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Vaccines are recognised as one of the greatest success in
biomedical science and public health.1 Thanks to vaccines, it
has been possible to eradicate once common diseases such as
smallpox and eliminate others such as poliomyelitis. In addi-
tion, according to data provided by the World Health
Organisation (WHO), the introduction of mass vaccination
has led to the halving of the number of deaths due to the most
common diseases prevented by vaccines. This saves between 2
and 3 million lives globally every year.2 Moreover, there are
significant gains in terms of cost effectiveness and benefits/
risks.2 However, the public perception of vaccines does not
always match the approval displayed in the scientific commu-
nity. By way of example, an investigation carried out in 67
countries by the Vaccine Confidence Project at the London
School of Hygiene & Tropical Medicine on the public’s opinion
of vaccines showed that only 24.57% of respondents in Italy
were absolutely convinced of the safety of vaccines.3 The lack
of confidence may have contributed to the decrease in immu-
nisation rates and to the consequent increase in the number of
cases of diseases such as measles, which in the 21st century
should by now have been eradicated.3-5 Italy has witnessed
plummeting rates of immunisation amongst newly-born
babies. Consulting the 2016 data about the 2014 cohort, for
the main infectious diseases that can be prevented by vaccina-
tion (poliomyelitis, diphtheria, whooping cough, hepatitis B,
measles, HIB meningitis, mumps, rubella, chickenpox,
Meningococcus C infections and pneumococcus infections),
the percentage of vaccinated subjects has fallen to alarmingly
low levels.5 It should be pointed out that only an adequate
level of vaccination can curtail the circulation of microbe
sufficiently to extend protection to those who for various
reasons cannot be vaccinated.6
Factors such as a capillary distribution network on the
territory and extended opening hours make the pharmacy
an indispensable forward base for the National Health
Service. This potential could be further exploited within any
vaccination programme. For some time now, pharmacies in
a number of European countries and other countries around
the world have been involved in vaccination campaigns;
numerous studies have demonstrated the success of this strat-
egy of using the pharmacy to provide vaccine information: to
illustrate the benefits and side-effects, to remind people of
their booster shots and, in general, to promote educational
programmes and awareness campaigns amongst the popula-
tion on the theme of vaccination.7
Over the last few years, pharmacists both in Europe and
worldwide have taken on a more active role in vaccination
campaigns; both stocking and distributing vaccines to General
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Practitioners (GP) and even administering vaccines directly in
the pharmacy such as in Ireland, Portugal, United Kingdom.7
It should be noted that in countries where this service has
been introduced, there has been not only an increase in the
immunisation rate, but important gains in the other activities
mentioned above.7
At present in Italy, pharmacies have only been involved in
some aspects within vaccination campaigns. The Piedmont
region, for example, decided to entrust some tasks to pharmacies
during the anti-influenza vaccination campaign in the 2016/
2017 season. In particular, Piedmont aimed to involve pharma-
cists in the attempt to raise awareness among the population of
the importance of vaccination through the use of posters and
brochures. In addition, pharmacies in Piedmont co-operated
with GP and Primary Care Pediatrician (PCP) to identify sub-
jects with the highest risk of developing complications as
a consequence of influenza to be referred for vaccination. The
GP and PCP also relied on the pharmacies to receive the
required doses of influenza vaccine.8 However, pharmacists in
Italy are not yet authorised to administer vaccines.7,9-12
The main aim of this study was to evaluate, by the use of
a questionnaire, the attitudes of pharmacy customers regarding
the proposal that pharmacists be allowed to administer vaccines.
Furthermore, customers’ attitudes to vaccines were recorded in
order to understand whether the respondents have confidence in
the safety and efficacy of vaccines; whether respondents have
doubts about their safety or they are strongly opposed to vacci-
nation. Successively, we identified which, if any, variables influ-
ence public opinion, either positive or negative, on vaccines.
Another aspect taken into consideration in the study was how
the population regards the figure of the pharmacist as
a counsellor on the subject of vaccines, compared to other
sources of information such as GP or the Internet, in order to
promote the pharmacist’s role in this field.
Results
A total of 320 subjects agreed to participate in the study. 135
individuals refused to take part to this study 62 of whom were
females and 73 males. On the contrary the majority of respon-
dents were females (65%). The average age of interviewed
subjects was 52.98 years (SD 16.03 years). Comparing the
same values between the two subgroups (favourable and
opposed to the proposal that pharmacists could administer
vaccines), it can be noticed that the average age is slightly
higher among those who declared themselves opposed to the
proposal that pharmacists could administer vaccines
(54.55 years, SD 15.36 years) compared to those in favour
(52.71 years, SD 16.15 years). The t-test shows, however, that
this difference is not significant (p = 0.47).
One of the main questions of the study concerns the possibi-
lity of the introduction of a pharmacy vaccinating service: 85% of
respondents affirmed that if pharmacists were authorised to
administer vaccines, they would avail of this service.
Only 15%, on the contrary, affirmed that they would con-
tinue to rely on their GP or public health centre for vaccina-
tion even if this service was available at the pharmacy. From
the data gathered, it can be noticed that among those who
declared that they would not utilise the vaccination service at
a pharmacy, there is a slightly higher percentage of those who
considered a pharmacy as an inappropriate place for the
administration of vaccines (55%).
The analysis of the data suggests an association between
the desire for the creation of the position of vaccinating
pharmacist and having an elderly person to care for
(PR = 1,10; p = 0,025).
As far as attitudes to vaccines are concerned, 76% of
respondents affirmed that vaccines are safe and effective.
Moreover, the data gathered seem to suggest a greater prob-
ability of being in favour of pharmacists administering vac-
cines amongst those who have favourable attitudes to vaccines
(PR = 1,15; p = 0,039).
The questionnaire also included some questions focusing on
practical aspects of the vaccination service in pharmacies e.g.
whether respondents would be willing to pay a share of the costs
to the health system13 for this service in order to avail of it. On
this subject, 51% of the respondents declared that they would not
be willing to pay to make use of this service.
Amongst the 273 individuals who declared that they would
make use of the vaccination service in pharmacies, there was
a clear majority (67%) in favour of using an appointment
system rather than simply coming during particular hours
set by the pharmacy for all customers.
The study also focused on two other factors: the distance
between the respondent’s home and the nearest pharmacy, and
the distance between respondent’s home and the nearest public
health centre. From the data gathered, it could be concluded that
there is no significant link between the distance to the nearest
public health centre and attitudes to vaccinations being admi-
nistered by pharmacists. Indeed, the percentage of favourable
responses to the question of pharmacists being authorised to
administer vaccines among those respondents who lived within
5km from the nearest public health centre was 86%; amongst
those who lived at a distance of more than 5km, the percentage
of favourable responses was 84% (p = 0.37). Nor did the distance
between home and the nearest pharmacy create a significant
distinction between those in favour or against pharmacists
being authorised to administer vaccines. Indeed, the percentage
of those in favour of pharmacists administering vaccines
amongst respondents living within 5 km of a pharmacy was
84% while 86% of individuals living outside a 5 km radius were
in favour (p = 0.80).
Concerning educational qualifications, among those who
declared to have a primary school education it can be noticed
an higher percentage of those who were contrary to the
introduction of a vaccine service in pharmacies (33%) if
compared with respondents with a higher level of education.
As regards the other levels of educational qualification con-
sidered (middle school diploma, high school diploma, univer-
sity degree), there are no significant differences and,
moreover, in all three cases, the percentage of respondents
in favour of using the vaccination service in pharmacies
exceeded 80%; therefore, showing a great deal of appreciation
for this service. The statistical analysis of the data revealed
that this difference is not significant (p = 0.31).
The study also investigated the correlation between occu-
pation and attitudes to vaccination services being introduced
in pharmacies. In order to glean more information from the
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data gathered, it was decided to calculate the percentages for
different occupations in the two sub-groups: those in favour
and those opposed to vaccination services in pharmacies. The
percentage of those not in paid employment such as retired
people, students and the unemployed was very similar in both
sub-groups (p > 0.05). Retired people, students and the unem-
ployed accounted for 30%, 5%, and 5% respectively of the
population of those in favour of the introduction of
a vaccination service in pharmacies; amongst those opposed
to the introduction of this service, these groups made up 30%,
2% and 6% respectively of the total of the subgroup.
Another result of interest that emerged from the data gathered
was the absence of a statistically significant difference in attitudes
to vaccines based on educational background (p = 0.18).
The study also set out to investigate the principal sources of
information regarding vaccines used by respondents. Themajor-
ity of the respondents (56%) affirmed that their GPwas their first
choice to obtain information about vaccines while the pharma-
cist was seen as a reference on the subject of vaccines by only 8%
of interviewees. Furthermore, almost all the respondents (93%)
believe that the sources of information they availed of were
trustworthy even if the majority of respondents (80%) felt that
healthcare professionals were still the most reliable sources when
compared to the web or mass media.
Another point revealed by the study regarded compliance
with the vaccination schedule: 87% of the respondents
declared that they had complied with the schedule.
Discussion
Based on a literature search, this is the first such study carried
out in Italy examining the introduction of a vaccination service
in pharmacies. Although the sample size of the interviewed
population was small, the results obtained are encouraging:
85% of respondents affirmed that if pharmacists were authorised
to administer vaccines, they would avail of this service. This may
lead to a desirable increase in the rate of vaccination amongst the
population as observed in other countries where the pharmacist
is authorised to administer vaccines.7,14 Hence, the pharmacy
will demonstrate and confirm once again its indispensable role
as a healthcare centre thanks to the longer opening hours,
a capillary network on the territory and the trust placed in
them by the public. Furthermore, the data gathered seem to
suggest a higher appreciation towards the introduction of
a vaccinating service in pharmacy amongst subjects with an
elderly dependant relative. This would seem to indicate, there-
fore, that in the management of the vaccination schedule for the
elderly, as in the example of the influenza vaccine, the pharmacy
could lend a helping hand that would be gratefully appreciated
by the public.
The percentage (55%) of those who affirmed that the
pharmacy is not an appropriate place for administration of
vaccines is probably attributable to the fact that in the event of
an allergic reaction, the pharmacist would not be capable of
dealing with the emergency. However, this issue can easily be
overcome by providing proper courses at under-graduate
pharmacy degree courses and ensuring that any pharmacist
wishing to administer vaccines receives adequate training on
vaccination procedures as required in those countries where
pharmacists are already authorised to administer vaccines.7
The introduction of a vaccinating service in pharmacies
could, however, encounter some potential financial obstacles:
a significant percentage of respondents, 51%, declared that they
would not be willing to pay for this service. The high percentage
of those who would not be prepared to pay for this service may
be explained by the fact that, at present, vaccines included in the
vaccine schedule are supplied and administered free of charge in
Italy.15 Moreover, there are also other obstacles to be considered:
other healthcare professionals may oppose the introduction of
a vaccination service in pharmacies.
Compared to the results of other surveys,3 not conducted in
pharmacy, the high percentage of those who declared that vac-
cines are safe and effective may be due to a social desirability bias.
Furthermore, the highest percentage of those who believe
that vaccines are unsafe and ineffective was recorded in phar-
macies located near an ethnic-religious community which is
openly contrary to the use of vaccines.16
Since the scientific community unanimously supports the
safety and efficacy of vaccines, a correlation between higher
educational levels and greater support for vaccination as a safe,
effectivemethod was expected to emerge from the data gathered.
Actually, scientific literature reports that in those countries with
a highly educated population and greater access to healthcare
services, there is a greater aversion to vaccines.17
According to the data gathered a low percentage of respon-
dents had not completed the course of vaccinations. This may be
due to the fact that, given the average age of the respondents, the
majority of those who took part in the study belong to the
generations for whom vaccination for some diseases was com-
pulsory in order to attend school; a regulation abolished in
1999.18 This correlation cannot, however, be taken for granted,
in other European countries such as Romania, despite the pre-
sence of compulsory vaccination, the immunisation rate is still
relatively low.19 Another interesting case is the Baltic countries:
Latvia, where vaccination is compulsory, does not reach the
same immunisation rate as the other countries in the region
such as Estonia and Lithuania, where vaccination is facultative.19
The Italian government recently changed the law regarding
compulsory vaccination; law n. 119 of 31 July 2017 made it
compulsory for children to be vaccinated against: poliomyelitis,
diphtheria, tetanus, Hepatitis B, whooping cough and
Haemophilus influenzae type b. The situation for four other
vaccines is slightly different under the new law: vaccination for
mumps, rubella chicken pox andmeasles will remain compulsory,
but the Minister of Health, on a three-yearly basis and in agree-
ment with the Italian Pharmaceutical Agency and the Higher
Institute ofHealth,may review the situation andorder the removal
of one or more of these vaccines from the list of compulsory
vaccines.20Unlike the trends in other countries, the reintroduction
of compulsory vaccination seems to have been a success; according
to the early statistics following the approval of this new law, there
has been a significant increase in the immunisation rate.21
Finally, the project foresees a repetition of the study in a larger
city such as Turin, in a longer time of data collection and
involving a greater number of pharmacies and respondents in
order to confirm the results obtained in the present study.
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Materials e methods
The work herein was designed as a cross-sectional study and
should be regarded as a pilot study to gather preliminary data
with the view of expanding the research project to a wider area.
The data collectionwas carried out fromMay 2017 to June 2017 in
8pharmacies recruited on a voluntary basis, all within the province
of Turin located in the same local health district. The pharmacies
were selected to obtain as wide a range of locations, number of
customers per day and business turnover as possible. Five of these
pharmacies are located in towns with a population greater than
5,000 inhabitants.22 The remaining three are located in towns with
a population of fewer than 5,000 inhabitants.22
The data were obtained by means of a face-to-face inter-
view using a questionnaire. A trained interviewer carried out
the survey with the first 40 adult customers who indicated
their willingness to participate in the study. The interviewer
who conducted the survey was adequately trained and there-
fore it can be excluded that he may have influenced the
answers of the interviewees. The questionnaire used was
divided into three sections and mainly composed of close
ended questions. The first section focused on general back-
ground information such as age, sex, education, occupation
and residence. The second section regarded the respondent’s
attitudes to vaccines and their sources of information relating
to these. This section also investigated whether the respon-
dents were actively involved in caring for a family member in
an age group, e.g. young child or elderly person, who should
be vaccinated every year. The third and final section con-
tained the most important question with regards to the aims
of this study: “If pharmacists were authorised to administer
vaccines, do you think you would make use of this service?”.
This question acted as a screening one; this is a kind of
question that allows the interviewer, according to the answer
provided, to omit other questions and proceed directly to
a successive one.23 In the case of an affirmative answer, the
respondent was asked question 3; “If so, would you be willing
to pay for this service?” and then question 4;” If so, would you
prefer to make an appointment or come during certain hours
open to all customers?”. Instead, in the case of a negative
answer, the interviewer continued with the question; “If not,
why not?”.
The survey was piloted on a small group of pharmacy
customers for readability, understanding and reliability.
The data gathered were analysed using a calculation of the
absolute frequency and the relative percentage frequency. The
average value and the Standard Deviation (SD) was calculated
for the age variable. The comparison between proportions and
average values was obtained by χ2 test and t-test. The indicator
selected for the associations is the Prevalence Ratio (PR). The
model used for the calculation of PR was a modified Poisson
regression with robust standard errors. The level of significance
was fixed at 0.05; IC at 95%
The statistical analysis was performed using the STATA14®.
Study limitations
A sampling bias could have occurred because of the recruitment
method (voluntary participation of each subject in the study).
Furthermore, some of the data may not be accurate enough as
a result of self-reported information. Another limitation could be
the period of data collection that was only two months.
Moreover, the findings may be very setting-specific and
may be influenced by the relationship with the pharmacy and
other local factors that are very difficult to control for.
Ethics statement
The subjects gave an informed consent and the subjects par-
ticipated in the study on a voluntary basis. Moreover, the
interviewees were chosen neither because of a particular ill-
ness state nor the assumption of a specific drug; the respon-
dents were instead randomly selected and moreover they were
informed on the characteristics and the purpose of the study.
The questionnaire was anonymous, personal data were not
collected and there is no way to trace back the answers to
a specific responder.
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